No Data
No Data
Profound Medical Unveils Q2 2024 Financials
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free
Profound Medical Upgraded at Stifel on Medicare Policy Update
Profound Medical Shares Are Trading Higher After Stifel Upgraded the Stock From Hold to Buy.
Profound Medical Shares Are Trading Higher After Stifel Upgraded the Stock From Hold to Buy.
Stifel Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $12
Stifel analyst Rick Wise maintains $Profound Medical(PROF.US)$ with a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 58.0% and a
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Mizuho